학술논문

Evidence for the efficacy and safety of anti-interleukin-5 treatment in the management of refractory eosinophilic asthma.
Document Type
Article
Source
Therapeutic Advances in Respiratory Disease; Aug2015, Vol. 9 Issue 4, p135-145, 11p
Subject
Language
ISSN
17534658
Abstract
Copyright of Therapeutic Advances in Respiratory Disease is the property of Sage Publications Inc. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)